200 related articles for article (PubMed ID: 12907124)
1. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995).
ACOG Committee on Practice Bulletins
Obstet Gynecol; 2003 Aug; 102(2):417-27. PubMed ID: 12907124
[TBL] [Abstract][Full Text] [Related]
2. ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003.
American College of Obstetricians and Gynecologists
Int J Gynaecol Obstet; 2003 Nov; 83(2):237-47. PubMed ID: 14631934
[TBL] [Abstract][Full Text] [Related]
3. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
4. HPV testing in cervical screening.
Cuzick J
Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
[No Abstract] [Full Text] [Related]
5. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
7. Persistent HPV infection and cervical cancer risk: is the scientific rationale for changing the screening paradigm enough?
Franco EL
J Natl Cancer Inst; 2010 Oct; 102(19):1451-3. PubMed ID: 20841606
[No Abstract] [Full Text] [Related]
8. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology screening in teens.
Moscicki AB
Curr Womens Health Rep; 2003 Dec; 3(6):433-7. PubMed ID: 14613663
[TBL] [Abstract][Full Text] [Related]
10. [Human papillomavirus and screening for cervical cancer: state of art and prospects].
Meijer CJ; Rozendaal L; Voorhorst FJ; Verheijen R; Helmerhorst TJ; Walboomers JM
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1675-9. PubMed ID: 10981235
[TBL] [Abstract][Full Text] [Related]
11. Global challenges of cervical cancer prevention.
Monsonego J
Clin Exp Obstet Gynecol; 2001; 28(1):5-13. PubMed ID: 11332590
[No Abstract] [Full Text] [Related]
12. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy.
Jastreboff AM; Cymet T
Postgrad Med J; 2002 Apr; 78(918):225-8. PubMed ID: 11930025
[TBL] [Abstract][Full Text] [Related]
13. The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination.
Monk BJ; Herzog TJ
Am J Obstet Gynecol; 2007 Oct; 197(4):337-9. PubMed ID: 17904955
[No Abstract] [Full Text] [Related]
14. Old and new issues in cervical cancer control.
Critchlow CW; Kiviat NB
J Natl Cancer Inst; 1999 Feb; 91(3):200-1. PubMed ID: 10037093
[No Abstract] [Full Text] [Related]
15. Comparison of cytology and cervicography in screening a high risk Australian population for cervical human papillomavirus and cervical intraepithelial neoplasia.
McKinnon KJ; Ford RM; Hunter JC
Aust N Z J Obstet Gynaecol; 1993 May; 33(2):176-9. PubMed ID: 8216120
[TBL] [Abstract][Full Text] [Related]
16. Cervical neoplasia: are adjunctive tests to cervical cytology worthwhile?
Greenberg MD; Sedlacek TV; Campion MJ
Clin Obstet Gynecol; 1995 Sep; 38(3):600-9. PubMed ID: 8612370
[No Abstract] [Full Text] [Related]
17. Human papillomavirus and cervical cancer: where are we now?
Kirwan JM; Herrington CS
BJOG; 2001 Dec; 108(12):1204-13. PubMed ID: 11843381
[No Abstract] [Full Text] [Related]
18. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
20. [Population screening for cervical cancer; eventual gain not expected to increase by testing for papillomavirus].
Giard RW; Coebergh JW
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1664-8. PubMed ID: 10981232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
